Comparaisons Financières Travere Therapeutics, Inc.
Actions
TVTX
US89422G1076
Recherche biotechnologique et médicale
|
Marché Fermé -
Nasdaq
22:00:00 14/08/2026
|
Varia. 5j. | Varia. 1 janv. | ||
| 62,14 USD | +1,16% |
|
+1,34% | +62,63% |
| 05/08 | Travere Therapeutics, Inc. : Wedbush favorable sur le dossier | ZM |
| 05/08 | Transcript : Travere Therapeutics, Inc., Q2 2026 Earnings Call, Aug 04, 2026 |
Principaux concurrents
Ajouter à une liste 0 sélectionné | Chiffre d'affaires (N-1) | Marge nette (N-1) | Marge EBIT (N-1) | ROE (N-1) | ROA (N-1) | Leverage (N-1) | |
|---|---|---|---|---|---|---|---|
 | 491 M | -5,21% | -12,8% | -57,8% | -4,26% | 5.32x | |
| 6,5 Md | 42,13% | 52,64% | 28,56% | 20,88% | -0.99x | |
| 4,25 Md | 30,41% | 24,81% | 20,15% | 17,36% | -3.18x | |
| 606 M | -210,54% | -205,59% | -249,28% | - | 0.72x | |
| 3,12 Md | 22,53% | 31,44% | 11,9% | 8,13% | -1.19x | |
| 3,37 Md | -39,59% | -48,95% | -5,88% | -5,1% | 6.99x | |
| 498 M | 32,27% | 31,52% | 16,97% | 14,74% | -3.83x | |
| 3,69 Md | 25,89% | 28,63% | 17,53% | 9,99% | -1.51x | |
| 294 M | -18,56% | -24,05% | -9,34% | -9,05% | 8.22x | |
| 2,32 Md | 33,73% | 37,59% | 35,53% | 27,02% | -1.18x | |
| 829 M | -0,2% | 11,86% | -0,5% | - | -6.61x | |
| 958 M | -30,08% | -31,31% | -42,49% | - | 2.15x | |
| 437 M | -36,42% | -29,57% | -7,45% | -7,74% | 6.67x | |
| 88,04 M | -891,6% | -695,44% | - | -55,55% | 0.05x | |
| 463 M | 21,89% | 22,29% | 25,37% | 11,13% | 2.45x | |
| 7,7 M | -6 046,22% | -6 714,77% | -40,17% | - | 2x | |
| 742 M | 42,2% | 49,8% | 35,4% | 31,62% | - | |
| Moyenne | 1,69 Md | -413,37% | -439,52% | -13,84% | 4,55% | 1,01x | |
| Moyenne pondérée par Capi. | 2,94 Md | -187,75% | -197,1% | -10,1% | 9,95% | 0,06x |
- Bourse
- Actions
- Action TVTX
- Secteur Travere Therapeutics, Inc.
- Comparaisons Financières
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national
